ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Autacoids ∟ Eicosanoids ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil 4 coordinate concepts ∟ 16,16-Dimethylprostaglandin E2 \| ∟ Arbaprostil \| ∟ Enprostil \| ∟ Misoprostol Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Autacoids ∟ Eicosanoids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil 4 coordinate concepts ∟ 16,16-Dimethylprostaglandin E2 \| ∟ Arbaprostil \| ∟ Enprostil \| ∟ Misoprostol Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil 4 coordinate concepts ∟ 16,16-Dimethylprostaglandin E2 \| ∟ Arbaprostil \| ∟ Enprostil \| ∟ Misoprostol Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil 4 coordinate concepts ∟ 16,16-Dimethylprostaglandin E2 \| ∟ Arbaprostil \| ∟ Enprostil \| ∟ Misoprostol Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Eicosanoids ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil 4 coordinate concepts ∟ 16,16-Dimethylprostaglandin E2 \| ∟ Arbaprostil \| ∟ Enprostil \| ∟ Misoprostol Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Eicosanoids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil 4 coordinate concepts ∟ 16,16-Dimethylprostaglandin E2 \| ∟ Arbaprostil \| ∟ Enprostil \| ∟ Misoprostol Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Fatty Acids, Essential ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil 4 coordinate concepts ∟ 16,16-Dimethylprostaglandin E2 \| ∟ Arbaprostil \| ∟ Enprostil \| ∟ Misoprostol X
Broader terms:	Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Autacoids ∟ Eicosanoids ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Autacoids ∟ Eicosanoids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Eicosanoids ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Eicosanoids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil Medical Subject Headings (MeSH) ∟ Lipids ∟ Fatty Acids ∟ Fatty Acids, Unsaturated ∟ Fatty Acids, Essential ∟ Arachidonic Acids ∟ Prostaglandins ∟ Prostaglandins, Synthetic ∟ Prostaglandins E, Synthetic ∟ Rioprostil Prostaglandins E, Synthetic > Prostaglandins, Synthetic > Prostaglandins > Arachidonic Acids > Eicosanoids > Autacoids > Inflammation Mediators > Biological Factors > Medical Subject Headings (MeSH) Prostaglandins E, Synthetic > Prostaglandins, Synthetic > Prostaglandins > Eicosanoids > Autacoids > Inflammation Mediators > Biological Factors > Medical Subject Headings (MeSH) Prostaglandins E, Synthetic > Prostaglandins, Synthetic > Inflammation Mediators > Biological Factors > Medical Subject Headings (MeSH) Prostaglandins E, Synthetic > Prostaglandins, Synthetic > Prostaglandins > Arachidonic Acids > Fatty Acids, Unsaturated > Fatty Acids > Lipids > Medical Subject Headings (MeSH) Prostaglandins E, Synthetic > Prostaglandins, Synthetic > Prostaglandins > Arachidonic Acids > Eicosanoids > Fatty Acids, Unsaturated > Fatty Acids > Lipids > Medical Subject Headings (MeSH) Prostaglandins E, Synthetic > Prostaglandins, Synthetic > Prostaglandins > Eicosanoids > Fatty Acids, Unsaturated > Fatty Acids > Lipids > Medical Subject Headings (MeSH) Prostaglandins E, Synthetic > Prostaglandins, Synthetic > Prostaglandins > Arachidonic Acids > Fatty Acids, Essential > Fatty Acids, Unsaturated > Fatty Acids > Lipids > Medical Subject Headings (MeSH) X
History note:	Anti-Ulcer Agents (1977-1991) \| Prostaglandins E (1975-1991) \| Prostaglandins, Synthetic (1977-1991)X
historyNote*:	92; was RIOPROSTIL (NM) 1985-91 X
onlineNote*:	use RIOPROSTIL (NM) to search RIOPROSTIL 1985-91 X
publicMeSHNote*:	92; RIOPROSTIL was indexed under PROSTAGLANDINS E 1985-91 X
Scope note:	A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1991-01-25X
dateEstablished*:	1992-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	RLSX
Type:	Concept X
Coordinate terms:	16,16-Dimethylprostaglandin E2 \| Arbaprostil \| Enprostil \| Misoprostol X
URI:	X
Labels and equivalent concepts:	Rioprostiili (fi) X
Share:	X